- Home
- VIVS vs IPDN Comparison
VIVS vs IPDN Comparison
Compare VIVS & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- IPDN
- Stock Information
- Founded
- VIVS 2007
- IPDN 2003
- Country
- VIVS United States
- IPDN United States
- Employees
- VIVS N/A
- IPDN N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- IPDN EDP Services
- Sector
- VIVS Health Care
- IPDN Technology
- Exchange
- VIVS Nasdaq
- IPDN Nasdaq
- Market Cap
- VIVS 4.7M
- IPDN 5.2M
- IPO Year
- VIVS N/A
- IPDN 2013
- Fundamental
- Price
- VIVS $3.19
- IPDN $3.16
- Analyst Decision
- VIVS
- IPDN
- Analyst Count
- VIVS 0
- IPDN 0
- Target Price
- VIVS N/A
- IPDN N/A
- AVG Volume (30 Days)
- VIVS 166.7K
- IPDN 2.7M
- Earning Date
- VIVS 11-07-2025
- IPDN 11-13-2025
- Dividend Yield
- VIVS N/A
- IPDN N/A
- EPS Growth
- VIVS N/A
- IPDN N/A
- EPS
- VIVS N/A
- IPDN N/A
- Revenue
- VIVS $142,000.00
- IPDN $6,459,379.00
- Revenue This Year
- VIVS $42.38
- IPDN N/A
- Revenue Next Year
- VIVS $15.42
- IPDN N/A
- P/E Ratio
- VIVS N/A
- IPDN N/A
- Revenue Growth
- VIVS 94.52
- IPDN N/A
- 52 Week Low
- VIVS $1.41
- IPDN $0.97
- 52 Week High
- VIVS $21.96
- IPDN $12.39
- Technical
- Relative Strength Index (RSI)
- VIVS 51.15
- IPDN 45.73
- Support Level
- VIVS $2.90
- IPDN $3.54
- Resistance Level
- VIVS $3.48
- IPDN $4.07
- Average True Range (ATR)
- VIVS 0.34
- IPDN 0.45
- MACD
- VIVS -0.09
- IPDN -0.08
- Stochastic Oscillator
- VIVS 20.86
- IPDN 19.41
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.